Skip to content

Role of PET/MRI in Head and Neck Cancer

PET/CT and PET/MRI Based Treatment Modalities in the Modern Oncology

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04360993
Enrollment
110
Registered
2020-04-24
Start date
2016-04-12
Completion date
2020-01-22
Last updated
2020-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Neoplasm, Head and Neck Cancer, Malignant Neoplasm

Brief summary

Study aim was to investigate the diagnostic role of Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) in head and neck cancer.

Detailed description

This study was assessed the role of Diffusion weighted imaging (DWI) in discriminating between benign and malignant lesions in Head and neck cancer as well as studying the relationship between glucose metabolism (18F-FDG) and Apparent diffusion coefficient (ADC) for better tumor assessment.

Interventions

RADIATIONRadiotherapy

Patients have received radiotherapy as a treatment modality for Head and neck cancer

Sponsors

University of Pecs
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
41 Years to 88 Years
Healthy volunteers
Yes

Inclusion criteria

* Proved Head and neck cancer * Underwent PET/CT and PET/MRI * Lymph nodes due to primary Head and neck cancer. For healthy subject: * No previous history of malignancy. * no inflammation or infection in the neck region. * lymph node size \<10mm.

Exclusion criteria

* patients treated before by radiotherapy / chemoradiotherapy * patients underwent surgery * artifacts

Design outcomes

Primary

MeasureTime frameDescription
Difference in Apparent diffusion coefficient value between benign and malignant lesionsBaselineApparent diffusion coefficient (ADC) was measured from benign and malignant lymph nodes by drawing region of interest (ROI) on the most homogeneous and most solid part in the target lymph node. Higher ADC value in Benign lymph node means that there are more water molecules movement inside the lymph node, more water molecules movement resulting in higher Apparent diffusion coefficient value. in malignant nodes and due to more tumor tissue, the result is to have lower water molecules motion so, lower ADC value.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026